Afya Limited(AFYA) Stock Research - Grey Stern Research
Loading...

Afya Limited (AFYA) Stock Analysis

$17.77 (-0.39%)

AFYA Financial Performance


Use the table below to view Afya Limited's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $17.77 -
52 Week Low $14.64 -
52 Week High $22.48 -
Market Cap $1.6 Billion 6/9
Gross Margin 61% 4/9
Profit Margin 20% 2/9
EBITDA margin 39% 1/9
Q2 - 2024 Revenue $178.9 Million 6/9
Q2 - 2024 Earnings $35.0 Million 4/9
Q2 - 2024 Free Cash Flow $42.0 Million 3/9
Trailing 4 Quarters Revenue $642.5 Million 5/9
Trailing 4 Quarters Earnings $116.0 Million 6/9
Quarterly Earnings Growth 106% 2/9
Annual Earnings Growth 35% 3/9
Quarterly Revenue Growth 22% 1/9
Annual Revenue Growth 10% 4/9
Cash On Hand $150.0 Million 6/9
Short Term Debt $42.4 Million 1/9
Long Term Debt $336.2 Million 4/9

Afya Limited Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Afya Limited's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 13.81 7/9
PS 12.15 1/9
PB 1.92 6/9
PC 10.69 5/9
Liabilities to Equity 0.96 5/9
ROA 0.01 8/9
ROE 0.03 8/9
Current Ratio 2.05 5/9
Quick Ratio 0.19 6/9
Long Term Debt to Equity 0.41 3/9
Debt to Equity 0.68 4/9
Burn Rate 8.89 3/9
Cash to Cap 0.09 4/9
CCR 1.20 5/9
EV to EBITDA 6.87 9/9
EV to Revenue 3.63 2/9

Company Details

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

CEO:

Website: https://www.afya.com.br

Address: Alameda Oscar Niemeyer, No 119, Sala 504 Vila Da Serra Nova Lima, MINAS GERAIS

Exchange: NASDAQ Global Select

Industry: Education & Training Services

Afya Limited Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Afya Limited. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Grand Canyon Education, Inc. LOPE $5.1 Billion
Adtalem Global Education Inc. ATGE $3.4 Billion
Laureate Education, Inc. LAUR $2.8 Billion
Strategic Education, Inc. STRA $2.5 Billion
American Public Education, Inc. APEI $306.2 Million
Stride, Inc. LRN $4.4 Billion
Lincoln Educational Services Corporation LINC $509.9 Million
Arco Platform Limited ARCE $927.4 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
AFYA Income Statements
Quarter Year Revenue Earnings
Q2 2024 R$ 871.3 Million R$170.2 Million
Q1 2024 R$ 804.2 Million R$203.4 Million
Q4 2023 R$ 729.9 Million R$98.1 Million
Q3 2023 R$ 723.5 Million R$93.3 Million
Q2 2023 R$ 712.6 Million R$82.8 Million
Q1 2023 R$ 710.0 Million R$112.1 Million
Q4 2022 R$ 584.0 Million R$66.7 Million
Q3 2022 R$ 580.6 Million R$75.8 Million

View All

AFYA Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 R$730.5 Million R$7.9 Billion R$2.7 Billion R$4.1 Billion
Q1 2024 R$611.1 Million R$7.7 Billion R$2.7 Billion R$3.9 Billion
Q4 2023 R$553.0 Million R$7.6 Billion R$2.6 Billion R$3.6 Billion
Q3 2023 R$822.0 Million R$7.8 Billion R$2.8 Billion R$3.5 Billion
Q2 2023 R$741.2 Million R$7.8 Billion R$2.8 Billion R$3.4 Billion
Q1 2023 R$722.7 Million R$7.8 Billion R$2.8 Billion R$3.3 Billion
Q4 2022 R$1.1 Billion R$7.2 Billion R$2.7 Billion R$3.2 Billion
Q3 2022 R$715.6 Million R$6.8 Billion R$2.2 Billion R$3.1 Billion

View All

AFYA Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 R$204.4 Million -R$42.3 Million R$117.0 Million
Q1 2024 R$325.0 Million -R$92.9 Million R$58.0 Million
Q4 2023 R$117.0 Million -R$30.4 Million -R$269.0 Million
Q3 2023 R$305.7 Million -R$53.0 Million R$80.8 Million
Q2 2023 R$150.2 Million -R$55.7 Million R$18.5 Million
Q1 2023 R$285.1 Million -R$46.4 Million -R$370.4 Million
Q4 2022 R$18.1 Million -R$110.0 Million R$377.4 Million
Q3 2022 R$213.4 Million -R$74.5 Million R$99.4 Million

View All